| Entry |
|
|---|
| Name |
Perzinfotel (USAN/INN) |
|---|
| Formula |
C9H13N2O5P
|
|---|
| Exact mass |
260.0562
|
|---|
| Mol weight |
260.1837
|
|---|
| Structure |
|
|---|
| Class |
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
|
|---|
| Efficacy |
Pain relief (neuropathic), NMDA receptor antagonist |
|---|
| Comment |
Treatment of neuropathic pain
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01498 NMDA receptor antagonist
D05447 Perzinfotel
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Glutamate (ionotropic), NMDA
GRIN (NMDAR)
D05447 Perzinfotel (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 17
1 C1x C 40.2952 -20.1373
2 C1x C 39.4508 -19.0247
3 C1x C 39.7869 -17.6642
4 N1y N 41.0514 -17.0845
5 N1x N 41.7048 -20.1626
6 C2y C 42.3083 -17.7085
7 C2y C 42.5956 -19.0810
8 C1b C 41.0031 -15.7058
9 C1b C 42.2304 -15.0228
10 C5x C 43.9681 -18.7937
11 C5x C 43.6808 -17.4212
12 O5x O 44.4427 -16.2560
13 O5x O 45.1189 -19.5455
14 P1b P 42.1817 -13.6506
15 O1c O 42.1817 -12.2506
16 O1c O 40.8102 -13.6749
17 O1c O 43.6098 -13.6253
BOND 18
1 3 4 1
2 1 5 1
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 2
8 4 8 1
9 8 9 1
10 7 10 1
11 10 11 1
12 6 11 1
13 11 12 2
14 10 13 2
15 9 14 1
16 14 15 2
17 14 16 1
18 14 17 1
|
|---|
